Article
Efficacy and safety of once-daily vs twice-daily dosing with fluvastatin, a synthetic reductase inhibitor, in primary hypercholesterolemia.
Archives of internal medicine - 14 Nov 1994
Insull W, Black D, Dujovne C, Hosking J D, Hunninghake D, Keilson L, Knopp R, McKenney J, Stein E, Troendle A J
Abstract excerpt
BACKGROUND: Fluvastatin sodium is a new, entirely synthetic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor that may be an effective lipid-lowering agent in patients whose hyperlipidemia does not respond to dietary therapy. We conducted a study to evaluate the effects of fluvastatin on lipoprotein levels in subjects with primary hypercholesterolemia and to compare the efficacy and safety of two...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.